Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1725160 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $4.92Day +5.35%Mkt cap $332M1Y +256.5%Off 52W high −29.2%Vol (1Y) 130.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,361 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest8.6% of sh out |
| Days to cover6.3d |
| 13F net flow (QoQ)−0.09% |
| Top-10 13F concentration54.1% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$124.1M |
| ROE−49.5% |
| ROIC−49.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+264.4% |
| 1Y+256.5% |
| 3Y−81.6% |
| 5Y−90.8% |
| Since incept. (ann.)−30.8% |
Total return through 2026-07-30 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)130.6% |
| Ann. volatility (3Y)108.5% |
| Sharpe (1Y)1.58 |
| Sharpe (3Y)0.00 |
| Max drawdown (1Y)−46.7% |
| Max drawdown (3Y)−96.3% |
| Beta (3Y vs SPY)2.27 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| 5AM Venture Management, LLC | 3.9M | $9M | 5.57% | +0.0% |
| Squadron Capital Management LLC | 3.6M | $8M | 5.12% | new |
| TWO SIGMA INVESTMENTS, LP | 3.0M | $7M | 4.17% | +100.9% |
| ACADIAN ASSET MANAGEMENT LLC | 2.8M | $7M | 4.02% | −0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $5M | 3.26% | new |
| RENAISSANCE TECHNOLOGIES LLC | 1.9M | $5M | 2.73% | −32.8% |
| CITADEL ADVISORS LLC | 1.7M | $4M | 2.44% | −11.8% |
| D. E. Shaw & Co., Inc. | 1.5M | $3M | 2.09% | −10.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.50 | — | — | — |
| 2025-12-31 | 2026-03-26 | — | — | $0 | −100.0% |
| 2025-09-30 | 2025-11-10 | −$0.37 | — | $0 | — |
| 2025-06-30 | 2025-08-06 | −$0.37 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 94d) — not company-confirmed.
